Health and disease in developing countries by Aaby, Peter & Samb, Badara
lnnkinnt KS, Bergström S ,  Mäkelä PH and Peltomaa M, eds. 
Health atid disease in deuelopitig countries. hdon:TlieMucnrillun Press Limited, 1994:163-176. 
MEASLES AND ITS CONTROL: 17 dogmas and new perspectives 
Peter Aaby, M.Sc. (Anthropology) 
Statens Seruminstitut, Epidemiology ORSTOM 
Research Unit BI? 1386, Dakar, 
Artillerivej 5, DK-2300 Copenhagen S, 
Denmark 
Badara Samb, M.D. 
Senegal 
INTRODUCTION 
ter presents somgdivergent interpretations of 
existing data on measles. Jn order to improve 
control of measles, much further research is 
The WHO estimated in 1987 that measles kills 
two million children annually, making it the 
major killer among vaccine preventable dis- 
eases. The estimate has declined in recent 
years to 0.9 million (1991) due to the improved 
immunisation coverage in developing coun- 
tries (DCs). Though the accuracy of these esti- 
mates can be discussed (see below), it is clear 
that measles poses a major public health prob- 
lem in DCs. Since the long-term effects of mea- 
sles have not been included in the above 
estimates, measles is likely to present a larger 
problem than usually understood. 
Measles has often been considered 'the sim- 
plest of all infectious diseases' (Maxcy). It is 
probably the most 'visible' infection due to a 
consistent clinical picture and the fact that vir- 
tually everyone contracted it before vaccina- 
tion was introduced in the early 1960s. 
However, %impie' does not imply that measles 
well-understood. Several recent studies have 
succeeded in disproving common beliefs 
about measles. 
Measles in DCs had hardly been studied be- 
fore the 1960s.l There are few community 
studies of this imDortant infection. This chap- 
SEVERE MEASLES 
Clinical and immunological features 
The following account focuses on measles 
mortality, which in epidemiological studies 
means any death occurring within one month 
of the rash. The common complication lead- 
ing to death is pneumonia. In one South 
African study of 21 children who died of 
pneumonia, one-quarter had active measles 
virus pneumonia, half had adenovirus or 
Herpes simplex pneumonia and one quarter 
had bacterial bronchopneumonia due to 
Klebsiella, Staphylococcus, or Pseudomonas.2 In 
some areas, diarrhea has been found to be a 
major complication of measles. Salmoilella has 
been associated with particularly severe 
diarrhea following measles. 
Giant cell pneumonia without a rash has 
been reported in children with kwashiorkor 
dying of measles, similar to what happens in 
leukemic children. Malnourished children 
with severe measles excrete giant cells for up 
to 4 weeks. This would suggest that they ex- 
crete more virus and are infectious for a long- 
er period than children with measles in 
industrialised countries. 1 
Immunological studies indicate that severe 
measles measured in terms of death or pneu- 
monia is associated with a low lymphocyte 
count (I 2.000 cells/ml), raised complement 
, 
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Table 17.1. Measles case fatality rates (CFR) in prospective community studies.9 
Country Immunization* CFR (number of measles cases) 
0-4 years All ages 
Africa - Rural 
Guinea-Bissau 
Gambia 
Senegal 
Senegal 
Kenya 
Nigeria 
Africa - Urban 
Guinea-Bissau 
Guinea-Bissau 
Zaire 
Other areas - Rural 
Guatemala 
Guatemala 
India 
Bangladesh 
Bangladesh 
Other areas - Urban 
India 
NI 
NI 
NI 
NI 
Ni 
I(20%) 
NI 
I 
I 
NI 
NI 
NI 
NI 
NI 
NI 
34% (101) 
20% (44) 
22% (259) 
18% (537) 
8% (331) 
7% (222) 
21% (356) 
15% (124) 
6% (1 069) 
5% (292) 
4% (231) 
3% (72) 
4% (510) 
2% (3458) 
0% (318) 
24% (162) 
13% (68) 
6% (424) 
17% (459) 
14% (161) 
4% (449) 
3% (276) 
4% (896) 
1% (181) 
* Nkno immunization; kimmunization programme (“’O coverage) 
component C3, low antibody response and 
depletion of T-helper and T-suppressor cells.3 
Though emphasis is on mortality as the ex- 
pression of severe measles, measles virus may 
have many other severe consequences. In one 
study from Nigeria, 25 per cent of the chil- 
dren lost 10 per cent or more of their weight 
during measles.1 Measles often precipitates 
kwashiorkor. It may lead to cancrum oris 
(Chapters 28 and 54) and is one of the major 
causes of deafness (Chapter 37). Most impor- 
tant is the fact that measles often precipitates 
blindness (Chapter 36).4 Several studies from 
Africa have shown that more than 50 per cent 
of childhood blindness is related to measles 
infection. The mechanisms are still under dis- 
cussion, but one study from Tanzania found 
that measles-precipitated blindness was asso- 
ciated with vitamin A deficiency (50 per cent), 
herpes simplex infection (21 per cent) or use of 
traditional eye medicine (17 per cent).4 It is 
not clear whether vitamin A deficiency was a 
preexisting condition or a result of the acute 
infection. 
Popular beliefs 
In most cultures measles has a specific name 
and is often a feared disease. In studies from 
West Africa, a good correspondence has been 
found between parental diagnosis and clini- 
cal or immunological findings. There may be 
some underdiagnosis of measles cases. 
However, a positive parental diagnosis is near- 
ly always correct. 
The popular understanding of measles is 
usually centred around the rash. In some so- 
cieties, the rash is believed to be the menstru- 
al blood retained during pregnancy which 
comes out.1 It is a common belief in all conti- 
nents that if the rash stays inside the body and 
does not come out the disease will be more 
severe. In a sense this is a correct observation 
since the prodromal period is prolonged in 
severe cases and in very severe epidemics, a 
large proportion of the deaths have occurred 
before the appearance of the rash.s.6 Given this 
emphasis on the rash, therapeutic practices 
are often geared to get the rash out, e.g. by 
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rubbing the skin with palm oil or kerosene. 
West Africa, attempts are made to main- 
tain the temperature since it is believed that 
cooling will keep the rash inside the body. 
Thus, the child may be bedded in hot sand, 
covered with blankets and not washed or 
given cold water to drink since this could cool 
the body, all practices that are likely to aggra- 
vate dehydration, 
Though some believe that measles can be 
caught several times, there is often a close cor- 
respondence with Western medical under- 
standing; everybody has to get measles but 
only once in a lifetime and it is more severe 
if caught as an adult. However, in contrast to 
the scientific understanding that measles infec- 
tion in vaccinated children is due to vaccine 
failure, African mothers often believe that vac- 
cinated children get milder measles infection.7 
ESTIMATING MEASLES MORTALITY 
The WHO estimate (1987) of two million mea- 
sles deaths annually was based on the assump- 
tion that of the 83.3 million children in DCs 
surviving annually to the age of one year, only 
24 per cent were protected by vaccination. The 
remaining children all get measles and the case 
fatality rate (CFR) of these children is 3.2 per 
cent on the average. The CFR has been as- 
sessed to be 3 4  per cent throughout Africa 
and Asia, and 2 per cent in the major countries 
of South America.8 It is very difficult to assess 
the CFR in many of these areas due to lack of 
reliable registration. The available data of CFRs 
in longitudinal community studies are sum- 
marised in Table 17.1.9 With few exceptions, 
the CFRs in these studies exceed the WHO 
estimate. For West and Central Africa, mortal- 
ity in the community may well be two to three 
times higher than the estimated 3 per cent. 
During recent years, immunisation coverage 
has increased, and by 1991 the estimated num- 
ber of deaths from measles had decreased to 
0.9 million children. 
INTERPRETATIONS OF SEVERE 
MEASLES 
An adequate understanding of the epidemi- 
ology of measles should be able to account for 
the major variations in measles mortality as 
outlined in Table 17.2.9-20 Measles virus is con- 
sidered to be stable, and differences in its vir- 
ulence are therefore unlikely to play a major 
role in the pathogenesis of severe measles.' 
Table 17.2. Relative contrasts in measles case fatality rates (CFR). 
High CFR Low CFR 
Africa Asia, Latin America 
West Africa East Africa 
Rural areas Urban areas 
Virgin soil epidemics Endemic situation 
Europe 1900 Europe 1940 
Extendedlpolygynous families Monogamous families 
High birth ratelmany siblings 
Short spacing Long spacing 
Twins Singletons 
Multi-family dwellings Single family housing 
Small apartments (few rooms) Many rooms 
Institutions (refugee camps, 
military camps, orphanages) 
Genetic (HLA-Aw32) 
Chronic conditions: TB, leukemia, kwashiorkor 
Infants, adults Children 
Males Females 
Female closed societies 
Females Males 
Unimmunised Immunised 
Low birth rate/few siblings 
Immunoglobulin prophylaxis 
Treated with Vitamin A 
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Table 17.3. State of nutrition and severity of measles in community studies (w/h = weight-for-height; 
= weight-for-age; muac = mid upper-arm circumference). 
Country Age Index Nutritional status (“7 standard) Type of 
(years) Fatal cases (N) Controls (N) control 
Bangladesh 0-9 
0-2 
3-9 
Guinea-Bissau 0-4 
0-5 
0-1 
Kenya 
Zaire 0-4 
Gambia 
Gambia 0-2 
Nigeria 
India 0-2 
India 0-4 
Philippines 
wlh 
w/h 
wlh 
wla 
wla 
hla 
wlh 
wla 
muac 
wla 
wlh 
muacla 
wla 
wla 
wla 
wla 
wla 
86% (33) 88 % (33) No measles 
93% (4) 86 Yo (1 48) Measles survivors 
85% (5) 88 Yo (1 70) Measles sutvivors 
Measles survivors 87% (1 7) 90 % (27) 
92% (60) 92 % (1188) All children 
97% (60) 97 % (1 172) All children 
97% (60) 98 % (1167) All children 
88% (1 O) 89 % (36) Measles survivors 
84% (31) 86 % (36) Measles survivors 
12% (6151) <3rd; 53% 40th centile 
6% (3150) <3rd; 56% 40th centile 
12% (6151) <3rd; 55% <50th centile 
29% (2/7) of fatal cases were malnourished. More than 29% 
malnourished among controls 
State of nutrition did not affect severity 
No relation between malnutrition and severe measles 
Among malnourished children, 29% had severe measles 
and 29% lost weight; among children of normal nutrition 33% 
had severe disease and 56% lost weight 
Severely malnourished children (<60% of wla) had the same 
rate of complications and the same immunological 
responses 
Well-nourished and undernourished had similar course and 
outcome of their illnes 
Instead, most explanations have emphasised 
host and care factors, particularly malnutri- 
tion, age at infection, type of complications 
and availability of medical care.1117 
Host and care factors 
Malnutrition. Only one community study, 
from Bangladesh, has documented higher mor- 
tality among malnourished children. In this 
study, 2019 children aged 12-23 months were 
followed for 2 years. During this period, chil- 
dren with a weight-for-age (w/a) of less than 
65 per cent of standard had a mortality risk of 
1.5 per cent compared with 0.6 per cent for the 
children with a w/a of more than 65 per cent.lS 
However, this comparison may be partly con- 
founded because it is based on deaths in rela- 
tion to the total population rather than in 
relation to the number of children catching in- 
fection. Since children from large families have 
lower w/a  and a higher risk of contracting 
measles, part of the reason for the higher risk 
of dying of measles among children under the 
w/a percentage of 65 may be a higher inci- 
dence of measles. Furthermore, in this com- 
munity, females had lower w/a and a higher 
CFR in measles. overrepresentation of females 
in the < 65 per cent group could also partly 
explain the higher mortality. 
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Table 17.4. Case fatality rate (CFR) in measles infection by age and type of exposure. Bandim, Guinea- 
Bissau, 1979. - 
Age 
(months) 
0-5 
6-1 1 
12-23 
24-35 
36-59 
60t 
CFR (Yo) (deathslno. ill) 
Houses with multiple cases 
Isolated cases Index cases Secondary cases 
0% (Oh) 24% (4/17) 
14% (In) 0% (0/15) 42% (11/26) 
0% (0/10) 14% (2114) 38% (14/37) 
0% (0/10) 5% (2138) 13% (5/39) 
33% (1/3) 6% (2/36) 0% (0/50) 
11% (2/19) 21% (3/14) 33% (14143) 
Total 8% (4/50) 8% (9/117) 23% (48/212) 
Hence, there seems to be no evidence (Table 
17.3) that malnutrition is a major determinant 
of measles mortality. Even though future stud- 
ies may find some association between nutri- 
tional state and measles mortality, it could 
explain only a small part of the variation in 
mortality. For example, children in West 
Africa have a better nutritional status than 
children in Bangladesh or India but the mor- 
tality is much higher in West Africa (Table 
17.1). In Guinea-Bissau, weight-for-height 
(w/h) of children under 3 years of age was 98 
per cent of standard and the CFR was 25 per 
cent. In Bangladesh, w/h was only 87 per cent, 
but the CFR was no more than 3 per cent.9 
Vitamin A deficiency has been suggested as 
a major determinant, but no community study 
has examined whether the pre-morbid vitamin 
A status had an effect on the outcome. This is 
possible, but West Africa, where CFR is highest, 
is not known to be the most deficient area in 
vitamin A. The observation that survival was 
increased among patients who received vita- 
min A treatment may reflect the fact that se- 
vere measles had depleted vitamin A stores 
rather than indicating that vitamin A deficien- 
cy was the cause of the severe disease.16 
Age at infection. Since the CFR is usually high- 
est among the youngest children, it has been 
suggested that measles mortality should be 
particularly high where many children con- 
tract measles at an early age.loJ’ From this per- 
spective, it has been predicted that measles 
mortality would be lower in rural areas, where 
age at infection is higher, than in urban areas. 
However, there is good evidence that the CFR 
is higher in rural than in urban areas.9 
It has also been suggested that the decline in 
measles mortality in the industrialised world 
at the beginning of this century is related to an 
increase in the age at infection. There is, how- 
ever, no data to show that the age at infection 
did in fact go up when fertility rates de- 
creased, although children in small families 
supposedly get infected at a later age.10 On 
the contrary, it is known that the age at infec- 
tion fell from 5.5 to 4.4 years between 1944 
and 1968. 
In Guinea-Bissau, CFR fell as the nutrition- 
al state deteriorated and the mean age at infec- 
tion decreased.19 Differences in age of infection 
explain only a small part of the variation in 
mortality across different societies. The ma- 
jor differences are due to different age-spe- 
cific CFRs.1 
Type and severity of complications. Differ- 
ences in the incidence of potential complicat- 
ing infections and pre-existing diseases 
(tuberculosis, kwashiorkor etc.) may account 
for some of the variation in severity of mea- 
sles. For example, intercurrent malaria has 
been suggested to be the major cause of the 
high mortality in Africa. Furthermore, also 
the severity of the underlying measles infec- 
tion could influence the risk of complications. 
For example, in Guinea-Bissau, secondary 
cases had more pneumonia and diarrhea. 
Availability of medical care. It is usually as- 
sumed that mortality is lower where medical 
assistance is available.17 Reconvalescence 
serum and later immunoglobulin (Ig) undoubt- 
edly helped reduce measles mortality in the 
industrialised countries, because it provided 
protection for the most important risk group: 
young children exposed at home to a sibling 
with measles. In virgin-soil outbreaks, mortal- 
ity has also been lower among individuals who 
received Ig. However, Ig has only rarely, if 
ever, been used in measles control in Dcs. For 
the usual symptomatic treatment there are no 
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Table 17.5. Case fatality rate (CFR) in houses with two cases of measles. According to sex constellation. 
- 
Age group CFR in houses with two cases(deaths/cases) 
MF pairs MM or FF pairs 
Guinea-Bissau 
6-35 months 13% (5/39) 38% (14/37) 
Total 11% (6/56) 26% (16¡61) 
36-59 months 6%’ (1/17) 8% (2/24) 
Senegal 
4-41 months 8% (7/84) 12% (1 7/137) 
Total 5% (71138) 1 0% (1 9¡182) 
42-65 months 0% (0/54) 4% (2/45) 
good community studies which have analysed 
whether the type of medical care available has 
an impact on mortality or not. 
Transmission factors 
In contrast to the emphasis on host factors in 
the pathogenesis of severe measles, recent 
studies from Africa have emphasised that vari- 
ation in transmission may influence the 
severity of infection.9 Children contracting 
infection from someone outside the home, the 
so-called index cases, have a much lower CFR, 
comparable with the mortality of children in 
houses with only a single case (Table 17.4). 
These tendencies have been found in several 
studies from Senegal, The Gambia, Guinea- 
Bissau, Kenya, Bangladesh, England, Germany 
and Denmark.9 
Intensive exposure and dose of infection. 
Confounding factors cannot explain why sec- 
ondary cases have higher mortality than in- 
dex cases.9 Since secondary cases are more 
intensively exposed within the house than in- 
dex cases, it may be the intensity of exposure 
which determines severity of infection. 
Secondary cases presumably absorb a higher 
dose of measles virus and may also be more 
likely to contract complicating infection than 
the index case. The possibility that dose of 
measles virus is important for outcome of in- 
fection has rarely been considered, although, 
in experimental animal studies, it is well 
known that a high dose leads to a short peri- 
od of incubation and a high CFR. Human 
studies seem to indicate an association 
between short period of incubation, long pro- 
dromes and more severe course of infecti0n..5~6 
Cross-sex transmission. Surprisingly, stud- 
ies from Guinea-Bissau and Senegal have 
found that secondary cases have a higher mor- 
tality when infected by someone of the oppo- 
site sex instead of their own sex.20 As a 
consequence, mortality was higher in houses 
where a boy and a girl had measles together 
compared with houses with two boys or two 
girls (Table 17.5). There is no apparent soci- 
ological reason why cross-sex transmission 
should Iead to more severe infection. 
Variation in exposure and mortality 
If exposure is a major determinant of mortal- 
ity, it is expected that the proportion of sec- 
ondary cases is high where CFR is high. That 
is indeed what has been found so far (Table 
17.6). For example, there is an enormous dif- 
ference in the risk of intensive exposure 
between the two countries which we com- 
pared before; in Guinea-Bissau 61 per cent of 
the children under 3 years of age were secon- 
dary cases and the CFR was 25 per cent, in 
Bangladesh 14 per cent of the children of the 
. same age group were secondary cases and the 
CFR was only 3 per cent. 
The emphasis on exposure as a risk factor 
in severe measles suggests that socioeconomic 
and cultural conditions leading to the concen- 
tration of many susceptible children are major 
determinants of the risk of high mortality. 
Hence, institutions like polygyny, extended 
families, high birth rate and multifamily 
dwellings would increase the risk of intensive 
exposure and mortality.9 
Geographical variation. There is no doubt 
that West Africa has the world’s highest CFR 
in measles. This is related to the fact that West 
Africa has the highest proportion of polygy- 
nous families and the largest compounds and 
households.9 
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Table 17.6. Frequency of secondary cases and case fatality rate (CFR) in measles community studies. 
Country Age (years) cases (N) CFR (N) 
Rate of secondary 
~~~ ~ 
Guinea-Bissau 
Senegal 
England (1 885) 
Guinea-Bissau 
Guatemala 
Kenya 
Bangladesh 
USA 
Bangladesh 
Gambia 
0-2 
0-2 
0-2 
0-2 
0-4 
0-2 
0-4 
0-4 
0-2 
0-2 
61% (203) 
46% (90) 
56% (171) 
45% (77) 
38% (260) 
20% (3181) 
14% (156) 
22% (999) 
14% (71) 
8% (13) 
25 Yo (203) 
14% (100) 
20% (171) 
14% (77) 
5 % (292) 
6 %  (592) 
2 Yo (3458) 
10 Yo (30) 
3 %  (156) 
O Yo (13) 
The rural-urban difference in mortality is 
also influenced by the pattem of measles trans- 
mission. In urban areas, where measles is en- 
demic, siblings in a household will tend to be 
infected at a young age and not in the same 
year. Therefore, the risk of becoming a secon- 
dary case is relatively small. Conversely, in 
rural areas, where there is a long interval 
between epidemics, siblings are likely to be- 
come infected at the same time. The mean age 
at infection will be higher than in urban areas. 
Thus, children in rural areas have a higher 
risk of becoming exposed at home as a secon- 
dary case. This should increase the mortality 
of rural children relative to urban ones. This 
pattem has been documented in Guinea-Bissau, 
where the same ethnic group has been studied 
both in an urban and a rural environment.*g 
Age. Other aspects of the epidemiology of se- 
vere measles may also be related to the risk of 
intensive exposure. Virtually all studies have 
shown that measles is most severe for the 
youngest children under one year of age. 
Table 17.7. Case fatality rate (CFR) by age group. 
Usually, severi increases again for teenagers 
lief that childhood infections are more severe 
for adults. This U-shaped curve (Table 17.7) 
corresponds not to a biological model but to a 
social reality, Infections are transmitted 
between families in the age group with a high 
concentration of susceptible individuals. This 
age may vary according to social pattems of 
contact, e.g. age at schooling or the frequency of 
kindergartens. Most children infected at the 
age of inter-family transmission will be index 
cases infected outside the house. Children in- 
fected before or after that age have a much 
higher risk of being infected by a sibling who 
has brought the disease home. Since the sec- 
ondary cases are more severe, part of the ex- 
planation for the higher CFR among the 
youngest dddren and young adults lies in their 
higher risk of having been intensively exposed. 
Sex. Sex-related difference in severity could 
likewise be the result of variation in the risk of 
intensive exposure. Several studies from 
and young adu *i ts, supporting the popular be- 
England (1 963)* Guinea-Bissau (1 979-83)t 
Age (years) CFR (N) Age (years) CFR (N) 
O 1.11% (21 570) O 46.7% (15) 
1 0.54% (62 942) 1 52.4% (21) 
2-4 0.1 3% (266 984) 2 26.9% (26) 
3 40.0% (20) 
4 5.3% (19) 
5-9 0.07% (294 555) 5-9 4.5% (44) 
15- 1.75% (6 272) 
10-14 0.44% (1 8 059) 10- 11:8% (17) 
* Notifications 
Community study in rural area. 
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Table 17.8. Mortality during nine months of follow-up for measles patients and community controls in 
the Gambia.21 
Age at 
infection 
Mortality of 
Mortality of measles cases controls 
Acute 1-9 months 0-9 months 
later later 
3-11 months 18% (all) 56% (5/9) 3% (3/94) 
1-2 years 9% (3/35) 13% (4/32) 2% (3/190) 
3-4 years 6% (2131) 7% (2/29) 1% (11182) 
5-6 years 0% (0136) 6% (2/36) 1% (2/188) 
developed countries have indicated that girls 
contract infection at a younger age than boys. 
Apparently, they contract infection more eas- 
ily outside the home. Therefore, boys should 
have a greater risk of being exposed at home, 
and this may explain some of their excess mor- 
tality in industrialised countries. However, in 
cultures where girls are more confined to the 
home and boys attend school more frequently, 
girls may have a higher risk of being infected 
as a secondary case at home. In the one study 
from Senegal where this hypothesis has been 
examined, excess mortality among girls could 
indeed be explained on this basis.20 
Decline in mortality. At the tum of the cen- 
tury, when measles mortality was high, the 
proportion of secondary cases in industrial- 
ised countries was very high (Table 17.6). The 
risk of intensive exposure within the family 
has been greatly reduced due to diminished 
family size, urbanisation and public child care. 
In Guinea-Bissau, measles mortality fell si- 
multaneously with a fall in the frequency of 
secondary cases.19 However, this cannot ex- 
plain the whole change in mortality, because 
there are sti l l  secondary cases in the industri- 
alised world and there is virtually no mortal- 
ity any longer. Though improved medicd 
treatment may have played some role, it is like- 
ly that positive feed-back in disease transmis- 
sion has been important. Studies from 
Denmark and Kenya have shown that the se- 
verity of secondary cases depends on the se- 
verity of the index case. When the proportion 
of secondary cases is reduced in a commu- 
nity, more and more of the index cases will 
be mild due to infection from mild index cas- 
es rather than severe secondary cases. The 
implication is that secondary cases also 
become milder and that the general severity 
of measles in the community is gradually 
reduced. 
Delayed impact of measles 
Acute measles mortality is counted as death 
within one month of a measles rash. Though 
it is well recognised that measles may give 
rise to prolonged complications, such as 
diarrhea and respiratory problems, until re- 
cently there have been no studies of the long- 
term impact of measles infection. Within the 
last years, however, it has become clear that 
measles may have a profound effect on mor- 
bidity and mortality, also after the acute in- 
fection.821 
Delayed mortality after measles infection. 
The five studies available from West Africa 
all suggest that delayed mortality is at least 
two to three times higher among previous 
measles cases than among controIs.8 One of 
these studies from Gambia is summarised in 
Table 17.8.21 After acute infection and during 
the 9 months of follow-up, mortali9 among 
the previous measles cases was nine times 
higher than among c o m m ~ t y  controls. These 
results could be confounded by background 
factors distinguishing cases from controls. 
However, the difference in mortality seems 
so large that confounding is unlikely to be the 
whole explanation. 
Studies to date suggest that the risk is 
particularly high for children who have had 
measles before one year of age. Most studies 
have emphasised the period of 1-6 months 
after infection as the critical one, htensity of 
exposure has also been found to be important 
for the long-tem consequences. Hence, index 
i 
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cses have lower post-measles mortality than 
do secondary cases. 
There is some indication in studies from 
Guinea-Bissau and Senegal that excess mor- 
tality may not be very high if comparison is 
made with non-immunised controls rather 
than immunised controls. Hence, part of the 
excess mortality after measles infection may 
in fact be due to a non-specific beneficial ef- 
fect of measles immunisation among the con- 
trols selected for comparison. 
Early exposure to measles. Several studies 
from Guinea-Bissau have shown that children 
who live in houses where measles occurred 
during the first 6 months of their life had a 
mortality three to four times higher than com- 
munity controls between 3 months and 5 years 
of age.22 The difference in mortality could not 
be explained as a result of confounding fac- 
tors. Diarrhea deaths were particularly com- 
mon among the exposed children, Excess 
mortality was found among both the 20 per 
cent who had a history of measles and among 
those who did not. It is, however, possible that 
some of the children without a history of 
measles had, in fact, subclinical measles and 
that this infection could explain some excess 
mortality. 
*. The delaved, fatal form of measles known 
as subacuté sclerosing panencephalitis (SSPE) 
occurs mostly among children who have had 
measles early in life. 
Exposure during pregnancy. Measles during 
pregnancy has been a rare event in the in- 
dustrialised countries in the last decades. 
However, at the tum of the century it was a 
dreaded condition for both the mother and 
the fetus. Studies from virgin-soil epidemics 
have shown that pregnant women with mea- 
sles have a higher mortality than non-preg- 
nant women. In Greenland, mortality was 4.8 
per cent (4/83) among pregnant but only 0.6 
per cent (4/641) among other women aged 
15-34 years.6 Studies from Guinea-Bissau sug- 
gest that exposure during pregnancy may be 
dangerous even when the mother does not 
develop clinical measles. Children of a moth- 
er who lived in a house with a case of measles 
had four times the risk of being stillborn or 
dying within the first week of life (Table 17.9). 
Conclusion. So far there are very few studies 
of the delayed impact of measles. There may 
therefore be doubts about the magnitude of 
the problem, and there are no explanations 
for the mechanisms leading to delayed mortal- 
ity. However, this area of study is potentially 
very important because it may ultimately 
demonstrate that measles virus has a much 
higher impact than commonly assumed. 
Immunity 
Measles immunity is usually considered an 
either-or phenomenon. However, observa- 
tions from DCs suggest that in some situa- 
tions, immunity is only relative. 
Maternal immunity. Children of immune 
mothers are usually assumed to be protect- 
ed by maternal antibodies, at least to the age 
of 6 months. However, in DCs cases of mea- 
sles are seen in children down to the age of 
2-3 months without the mother necessarily 
having measles concurrently. When children 
younger than 6 months have measles, it al- 
most always follows intensive exposure at 
home (or at a hospital). Antibody studies also 
indicate that many children under 6 months 
develop subclinical infection when exposed 
to a sibling with measles. 
Vaccine-induced immunity. It has been com- 
monly assumed that measles vaccine would 
produce a protective and lifelong immunity 
similar to natural infection. The large num- 
ber of cases of measles in vaccinated children 
Table 17.9. Perinatal mortality among children of mothers exposed to measles during pregnancy, 
Bandim, Guinea-Bissau, 1979. OR = Odds ratio (95 Yo confidence interval). 
Perinatal mortality risk (deathslat risk) 
Exposed Controls OR (95% CI) 
6.5% (7/107) 1.4% (5/346) 4.8 (1.7-13.8) 
Died 1st week 9.0% (9/100) 2.6% (9/341) 3.6 (2.3-5.6) 
15.0% (16/107) 4.0% (14/346) 4.2 (2.1-8.5) 
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observed in DCs have therefore been ex- 
plained as vaccine failures, i.e. children who 
did not seroconvert due to improper storage 
or handling of the vaccine or because of inter- 
ference from matemal antibodies. This expla- 
nation contrasts with popular perceptions in 
many parts of Africa that vaccinated children 
have a milder form of infection. Epidemiolog- 
ical studies have shown that mothersare cor- 
rect. Vaccinated children who develop 
measles have lower mortality.7 Vaccinated 
children are more likely to be secondary cas- 
es, which suggests that they contracted mea- 
sles only because of the intensity of exposure. 
This would indicate that some of the children 
have indeed had partial immunity from vac- 
cination. There are also a few reports of chil- 
dren who seroconverted after vaccination and 
subsequently developed clinical measles. 
The relative importance of different causes 
of vaccine failure are likely to vary in different 
regions. It is important to detect these causes 
in measles control programmes. In most re- 
gions, vaccine failure may be due to break- 
down of the cold chain and interference from 
matemal antibodies. However, it is important 
to recognise that partial immunity exists, since 
this has implications for the current vaccina- 
tion strategy (see below). 
Immunisation strategies 
Measles vaccination and mortality. Since mea- 
sles is believed to kill mostly malnourished 
children, it has sometimes been suggested that 
measles immunisation may have a limited im- 
pact on survival. It is thought that children 
saved from dying of measles will die of other 
infections instead. By this reasoning, nutrition 
and nutritional education is considered more 
important than immunisation. Since intensity 
of exposure is the major determinant of severe 
measles, it may not be the particularly weak 
children who die. Neither would they be more 
likely to die of other infections if surviving 
measles. Immunisation against measles should 
therefore have strong impact on mortality. 
A study from Zaire is often quoted as having 
shown that immunisation had little impact on 
mortality.23 In fact, the study found that in the 
critical period for child mortality, between 7 
and 35 months of age, vaccinated children had 
a mortality of 3.8 per cent, i.e. 45-60 per cent 
lower than the three unvaccinated control 
groups (7.0-9.5 per cent). In spite of large vari- 
ations in social settings and organisations, 
other studies of the impact of measles ìmmu- 
nisation have found very similar trends. The 
available studies from West Africa, Zaire, 
Bangladesh and Haiti suggest a reduction in 
child mortality after the age of vaccination of at 
least 30 per cent, and eight of the 12 studies 
found a reduction of 45-50 per cent or more. 
The beneficial impact of measles vaccination 
has been found both in urban and rural areas 
and in countries with both high and low over- 
all child mortality. 
All studies suggest that the reduction in 
mortality is larger than would be expected 
from a reduction in the number of acute mea- 
sles deaths. One possible explanation is in the 
delayed excess mortality of children with mea- 
sles. This effect is likely to be preventable by 
vaccination as well. Thus, there is no support 
for the view that measles infection functions as 
a mechanism of natural selection, merely tak- 
ing the weakest children likely to die anyway. 
However, the impact of measles immunisation 
on mortality seems larger than can explained 
by the prevention of the acute and long-term 
consequences of measles.8 
Herd immunity effect of vaccination. Apart 
from the direct effect of vacbination in pro- 
tecting some children from catching measles, 
vaccination also has an indirect effect. When 
some individuals are vaccinated in a commu- 
nity, there are fewer families where several 
children get measles simultaneously. As a con- 
sequence, the risk of intensive exposure is re- 
duced. The implication is that vaccination also 
reduces mortality among unvaccinated chil- 
dren who catch measles.*9 
Measles immunisation policy in 
developing countries 
The EPI (Expanded Programme on Immuni- 
zation) of WHO recommends immunization 
with a single dose of Schwarz attenua fed live mea- 
sles vaccine at fhe age of 9 nronths in DCs, Due to 
matemal antibodies, not more than 80-90 per 
cent may seroconvert at this age. In the indus- 
trialised countries, measles vaccination is de- 
layed to the age of 15 months or later in order 
to prevent interference from maternal anti- 
bodies. However, if immunisation was de- 
layed that long in DCs, an unacceptably large 
proportion of the children would already have 
contracted measles before the age of vaccina- 
tion. The 9-month age h i t  is a compromise 
between the need to protect children early and 
the lower seroconversion rate at lower ages. 
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Studies from Kenya on measles incidence 
a d  seroconversion rate in different age groups 
predicted that vaccination at 8 or 9 months 
would yield the same number of prevented 
cases, whereas postponement of vaccination 
to 10 months would imply that too many 
children had already had measles. The age 
of 9 months was then selected because vacci- 
nation at 8 months would mean more vac- 
che  failures, presumably leading to popular 
lack of confidence in the vaccine. However, 
this line of reasoning is debatable. Very of- 
ten mothers view mild measles as an advan- 
tage of the vacche and not as a reason to lack 
confidence. If vaccinated children indeed 
have milder measles and early cases have 
strong delayed mortality, it might save more 
lives to vaccinate at 7 or 8 months instead of 
waiting to 9 months of age.7 
Alternative immunisation strategies. With 
vaccination at 9 months, as many as 10-20 per 
cent may not seroconvert, and as many as 5-10 
per cent of the children may get measles be- 
fore this age, To find a strategy which could 
overcome these problems, experiments have 
been made with high-dose measles vaccine. 
The Edmonston-Zagreb (EZ) high-titre vac- 
cine induces a good serological response and 
provides clinical protection even when given 
as early as 4-5 months. In 1989, WHO there- 
fore recommended the use of EZ high-titre 
vaccine from the age of 6 months in areas with 
a high incidence before 9 months. However, 
subsequent follow-up to the age of 3 years in 
studies in Guinea-Bissau, Senegal and Haiti 
has documented that girls who have received 
high-titre vaccines had significantly higher 
mortality than girls who had received the stan- 
dard low dose schwarz measles vaccine. There 
was no difference for the boys.24 Hence, WHO 
has been obliged to change the recommenda- 
tion back to one dose at 9 months of age." 
It is worth emphasising that there is no sim- 
ple explanation of the higher mortality among 
female recipients of high-titre vaccines. The 
difference in mortality had nothing to do with 
differences in protection against measles.24 
Since the high-titre vaccine was not associat- 
ed with higher mortality in areas with low 
mortality or compared with control children 
who had not received the standard measles 
vaccine, it seems unlikely that the vaccine is 
dangerous in itself. Hence, the main problem 
may be that it does not entail the non-specific 
beneficial effect associated with standard 
Schwarz measles vaccine. 
Given the failure of high-titre vaccination, 
researchers are looking for a new vaccine. At 
the present time (1993), it seems likely that 
this may be a genetically engineered vaccine 
based on the canarypox virus as carrier. 
However, if the failure of the high-titre strat- 
egy is really due to the standard vaccine hav- 
ing non-specific beneficial effect, a new vaccine 
may also end up showing increased mortal- 
ity compared with the standard vaccine. It 
may therefore be advisable to consider the 
benefit of a two-dose schedule with Schwarz 
measles vaccine; the first probably at six 
months and the second at 9 or 12 months of 
age. Non-randomised studies from both 
Guinea-Bissau and Senegal have shown much 
better survival for children who received stan- 
dard Schwarz measles vaccine at 4 4  months 
of age than for children immunised at 9-11 
months. Without a vaccine which can be used at  
5-6 months of age, it will be impossible to  stop the 
transmission of measles. 
Transmission patterns and control of 
measles 
Measles transmission depends on contact 
between infectious cases and susceptible indi- 
viduals. There are no infectious carriers or non-hu- 
nian reservoirs. Measles is extremely infectious; 
when susceptible individuals are exposed at 
home, they nearly all catch the infection. In 
studies in DCs, the secondary attack rate, i.e. 
the proportion who develop infection after 
exposure at home, has been very high. 
Endemic-epidemic tendencies. Theoretical 
studies have suggested that a population of 
300 O00 is needed for continuous transmission 
of measles. Hence, the infection is endemic 
only in larger cities. However, even in cities 
there are seasonal fluctuations and cycles in 
the incidence pattem, with more cases every 
second or third year. One important conse- 
quence of the endemic pattem is that children 
in urban areas are much more likely to con- 
tract infection early in life. However, since 
their older siblings have usually already had 
measles there is less risk that measles cases 
will occur in groups of two or more. 
In smaller towns and rural areas, the pat- 
tem will be epidemic with introductions from 
the outside. Most of the susceptibles will be 
infected at the same time, after which the dis- 
ease disappears again. The interval between 
epidemics depends on both the size of the 
community and its degree of isolation. In 
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small isolated communities there may be long 
intervals, up to 10-15 years. Housing tradi- 
tions may also be important for the way 
epidemics proceed in rural areas. Where com- 
pounds are close together, the epidemic will 
sweep through the village, attacking most sus- 
ceptibles. In dispersed villages, an introduc- 
tion of measles may attack only a few 
compounds. 
Age and institutions of transmission. Inter- 
family transmission of measles occurs mainly 
in the age group where there is a high con- 
centration of susceptible children. Individuals 
outside this age range will have a higher risk 
of being secondary cases infected at home. 
The role of health care institutions needs to 
be particularly emphasised. Several commu- 
nity studies have shown that health centres 
and hospitals without isolation wards play a 
major role in the transmission of measles. In 
one urban community in Guinea-Bissau hav- 
ing a high vaccination coverage (> 80 per cent), 
half of the new introductions from outside the 
district were due to transmission at the hos- 
pital. It is also worth noting that children who 
catch measles at the hospital have much high- 
er mortality compared with those hospital- 
ised with measles. 
Control measures 
Improved vaccination coverage. Improving 
participation in vaccination programmes 
must have priority in measles control pro- 
grammes. Lowering the age at vaccination is 
likely to increase the coverage. Most studies 
have shown that coverage for vaccines re- 
ceived before 4-5 months of age (DPT and 
polio) is much higher than for those given at 
9 months. Acceptance of the rule of vacci- 
nating all children attending health centres, 
even when sick would help improve coverage 
sigruficantly . 
Prevention of intensive exposure. Since sec- 
ondary cases are a particular high risk group, 
intensive exposure at home should be pre- 
vented. Control of intensive exposure has not 
been attempted in DCs and the cost of immu- 
noglobulin will be prohibitive in most places. 
However, if the index case is detected in the 
early phase of the rash, the effect of vaccinat- 
ing susceptible contacts should be studied. 
Since the vaccine has a shorter period of in- 
cubation than the natural infection, it might 
be possible to prevent or attenuate some of 
the secondary cases. 
Priorities in measles control. It seems likely 
that the source of outbreaks in rural areas is 
often introduced from the cities. Transmis- 
sion in the rural areas would not be conk-  
ued unless constant reintroduction from the 
cities took place. Therefore, a priority to high 
coverage in urban areas may be indicated. 
There also seem to be good reasons to at- 
tempt containment of outbreaks in rural are- 
as. In outbreak campaigns, the age limit for 
vaccination has often been set at 2 or 5 years 
of age. However, experience from many ru- 
ral areas suggests that a large proportion of 
the cases occur among children who are more 
than 5 years old. 
Countrywide control or eradication of mea- 
sles. Measles is reported to have been absent 
from The Gambia in a 2-year period in the 
1960s, shortly after major campaigns were car- 
ried out simultaneously with the smallpox erad- 
ication programme. No other DC has attempted 
countrywide eradication of measles. A high de- 
gree of control requires at least the following: 
1) A new vaccination strategy which provides 
effective immunisation at the age of 5-6 
months. A two-dose schedule is probably nec- 
essary to prevent accumulation of susceptible 
non-seroconverters. 
2) Systematic vaccination at all health institu- 
tions, including pediatric departments. 
3) Some initiating vaccination campaigns to 
prevent outbreaks among susceptible older 
children who have accumulated due to isola- 
tion or previous vaccination activities. 
4) Annual campaigns just before the local mea- 
sles season. 
5) Improved surveillance and containment 
vaccination when measles is introduced in a 
community. 
CONCLUSION 
Severe measles has usually been understood 
as a mechanism of natural selection which 
takes the weakest children. However, avd -  
able data now suggest a quite different inter- 
pretation. Not only does measles kill many 
normal children in the acute phase of the infec- 
tion, it may also weaken many children so that 
they become susceptible to delayed morbiditY. 
It seems likely that future studies of the effects 
of measles will show that it kills considerably 
more than two million children annually. 
suggests that disease specific interventions 
be very important, in addition to improva 
The importance of transmission factors 
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h nutrition and hygiene.23 It is likely that mea- 
sles control is one of the most important public 
health interventions in terms of reducing child 
~ortality.l~s 
Future research 
Much more research is needed to improve 
understanding and control of measles. Some 
:of the major research questions include: 
1) What are the pathogenic mechanisms of se- 
vere measles? 
2) Why is measles infection connected with 
delayed morbidity and mortality? 
,3) How can intensive exposure be prevented? 
4) Why does standard measles vaccine have 
?non-specific beneficial effects? 
‘3) Why was high-titre vaccine associated with 
,‘higher mortality? 
,6) mat is the basis of the sex specific effects of 
: fie disease and of the vaccines? 
,‘7) What is the best vaccine and vaccination 
strategy? 
8) What happens to immunity when there is 
little re-exposure to measles? Will immunity 
wane and make revaccination necessary? 
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